The assay thereby presents a complementary tool to prioritize candidate treatments for further studies in genetically predisposed animal models of neuroblastoma such as the TH-MYCN mice48, the LIN28B transgenic mice53 or the D\documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{mathrsfs}\usepackage{upgreek}\setlength{\oddsidemargin}{-69pt}\begin{document}$$\beta$$\end{document}βh-EGFP-MYCN zebrafish harbouring coexpression of activated ALK and MYCN54. This evidence concerns the gene MYCN and neuroblastoma.